Renown Health re-accredited as a Level 3 epilepsy center

Renown Regional Medical Center is located off Mill Street just east of downtown Reno.

Renown Regional Medical Center is located off Mill Street just east of downtown Reno. Courtesy Photo

Share this: Email | Facebook | X

The Renown Institute for Neurosciences announced last month that Renown Health’s epilepsy program has been re-accredited as a Level 3 epilepsy center by the National Association of Epilepsy Centers (NAEC); it’s the only Level 3 epilepsy center in Northern Nevada.


“Renown Health is a destination for health in treating neurological disorders like epilepsy, and advancing innovations in neurology. The specialists at the Renown Institute for Neurosciences provide comprehensive brain, nerve and surgical support, along with a disease-specific, patient-focused approach to care,” Dr. Tony Slonim, President and CEO of Renown Health, said in a statement. “I am incredibly proud of our team. Re-accreditation from NAEC means consumers can be assured that Renown’s epilepsy program has once again met the most rigorous standards and that Renown is nationally recognized as a place for the highest-quality epilepsy care.”


NAEC accredits centers based on their expertise and capacity to provide specialized services related to vital epilepsy and seizure care, according to a May 20 press release from Renown.


“In addition to re-accreditation, Renown’s Institute for Neurosciences earned a Gold Seal of Approval by the Joint Commission, accreditation from the American Board of Registration of Electroencephalographic and Evoked Potential Technologists (ABRET),” Renown’s Chief Medical Officer of Acute Services, Dr. Paul Sierzenski, said in a statement. “Renown’s epilepsy laboratory implements some of the most innovative and contemporary treatments available in the country.


"Patients also have access to the most promising new therapies through national clinical trials, which have been shown to significantly improve health and wellbeing.”

Comments

Use the comment form below to begin a discussion about this content.

Sign in to comment